Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

7

Revenue 2014

GlaxoSmithKline

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of GlaxoSmithKline's 2013 sales performance.

AAA board presses go on $3.9bn Novartis takeover

AAA board presses go on $3.9bn Novartis takeover

The Swiss big pharma company has been steadily bulking up in cancer via bolt-on acquisitions, for example by buying up GlaxoSmithKline’s oncology assets in 2015 in a $16bn deal,

UK trumpets life sciences post-Brexit ‘sector deal’

UK trumpets life sciences post-Brexit ‘sector deal’ UK trumpets life sciences post-Brexit ‘ sector deal’. Highlights commitments from GlaxoSmithKline, AstraZeneca and MSD. ... £40m investment from GlaxoSmithKline (GSK) in drug target identification and a commitment from AstraZeneca (AZ) to continue

ViiV starts trial of HIV-preventing injections for women

ViiV starts trial of HIV-preventing injections for women ViiV - majority owned by GlaxoSmithKline, with Pfizer and Shionogi as shareholders - is planning to enrol 3, 200 women aged between 18 and 45 into the study, which will be carried out

Concordia accused of overcharging NHS for thyroid drug

Concordia accused of overcharging NHS for thyroid drug ruling. Meanwhile, earlier in 2016 the CMA fined number of pharmaceutical companies in relation to ‘pay-for-delay’deals that affected the supply of generic paroxetine, an antidepressant developed by GlaxoSmithKline.

Inceptua Medicines Access appoints senior new-hires

Inceptua Medicines Access appoints senior new-hires Prior to her new role, Gutteridge was medical executive at GlaxoSmithKline, where she was at the helm of the grants and donations process.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

Why pharma content marketing campaigns should be agile
Agile pharma content marketing is simply about responding to customer needs, rather than your own whims....
Grabbing your audience*
Highlighting one of our recent pieces of work - a powerful disease awareness film created in partnership with Watchable Films...
Defining Market Access and the Key to Success
Kevin Lennon, Head of Operations & Market Access at OUTiCO, shares his definition of market access and the key to success....

Infographics